Clinical Efficacy, Antibiotic Resistance Genes, Virulence Factors and Outcome of Hospital-Acquired Pneumonia Induced by Klebsiella pneumoniae Carbapenemase 2-Producing with Tigecycline Treatment in the ICU
Xiang-Rong Bai,1,* Jing-Rong Cao,2,* Zhi-Zhou Wang,1 Wen-Chao Li,1 Dian-Dian Chen,2 Ran Lou,3 Xin Qu,4 Su-Ying Yan1 1Department of Pharmacy, Xuan Wu Hospital Capital Medical University, National Gerontic Disease Clinical Research Center, Beijing, 100053, People’s Republic of China; 2...
Main Authors: | Bai XR, Cao JR, Wang ZZ, Li WC, Chen DD, Lou R, Qu X, Yan SY |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-09-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/clinical-efficacy-antibiotic-resistance-genes-virulence-factors-and-ou-peer-reviewed-fulltext-article-IDR |
Similar Items
-
Molecular Epidemiology of Antimicrobial Resistance, Virulence and Capsular Serotypes of Carbapenemase-Carrying <i>Klebsiella pneumoniae</i> in China
by: Lina Zhao, et al.
Published: (2022-08-01) -
Tigecycline and Community-Acquired Pneumonia
by: Sercan ULUSOY
Published: (2013-12-01) -
Genomic Epidemiology of Carbapenemase-producing Klebsiella pneumoniae in China
by: Cuidan Li, et al.
Published: (2022-12-01) -
Klebsiella pneumoniae Carbapenemase–2, Buenos Aires, Argentina
by: Fernando G. Pasteran, et al.
Published: (2008-07-01) -
Phenotypic and molecular detection of carbapenemase producing Escherichia coli and Klebsiella pneumoniae
by: Ibrahim Hussaini, et al.
Published: (2023-02-01)